Clinical trial Recruiting at 8 sites Interventional Ages 18 to 39

Glycolytic Power and Muscle Growth Response to Resistance Training

Official title: HyperLa: Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training: A Multi-centre Study by the HyperLa Study Group

Run by Technical University of Munich · NCT07721766 · Data updated 2026-11-12

The study tests whether a person’s glycolytic efficiency predicts how much their muscles grow after eight weeks of resistance training.

Quick facts

Study typeInterventional
Ages18 Years to 39 Years
SexAll
Enrollment120 (estimated)
SponsorTechnical University of Munich
Academic / other
Locations8 sites (Jyväskylä, Central Finland and 7 other locations)
StatusRecruiting
StartedMay 4, 2026
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedJuly 23, 2026
Trial IDNCT07721766 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults with BMI 20-29 kg/m2, no recent resistance training, limited aerobic activity, and no contraindicating medical conditions.

Probably not a fit

Individuals with recent structured training history, current cardiovascular or metabolic diseases, or conditions preventing exercise may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter study looks at whether the glycolytic phenotype, measured by the vLapeak lactate peak during a short all-out sprint, can forecast lower-body muscle hypertrophy after an 8-week resistance program. Participants will undergo the vLapeak test, then complete twice-weekly supervised leg-focused training with progressively challenging loads. Muscle size will be assessed with ultrasound before and after training, while blood metabolomics and optional muscle biopsies explore metabolic changes that relate to hypertrophy. The study uses a single-arm design to link metabolic phenotype with physical adaptation in healthy adults.

Why it matters

Potential benefit: If successful, results could support personalized training plans based on metabolic profiles to optimize muscle growth.

How similar studies have gone: Previous work has shown metabolic phenotypes can relate to exercise responses, though this specific vLapeak–hypertrophy link is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Body Mass Index (BMI) between 20-29 kg/m2
* No structured resistance training performed in the last twelve months.
* Maximum of four sessions per week of recreational or low-to-moderate aerobic endurance activity.
* No history of competitive strength or physique sports.

Exclusion Criteria:

* Diagnosed cardiovascular, pulmonary, metabolic, neuromuscular, or orthopaedic disease that contraindicates exercise.
* Positive response to any question on the PAR-Q 2025 questionnaire.
* Current use of anabolic steroids, creatine, or other substances known to strongly influence muscle hypertrophy.
* Regular engagement in shift work.
* Women who are pregnant or breastfeeding.

Where it's running

  • University of Jyväskylä, Faculty of Sport and Health Sciences
    Jyväskylä, Central Finland, Finland
    Recruiting
  • Technical University of Munich, TUM School of Medicine and Health
    München, Bavaria, Germany
    Recruiting
  • DLR Cologne, Department of Metabolism and Human Performance
    Cologne, North Rhine-Westphalia, Germany
    Recruiting
  • iST University of Applied Sciences
    Düsseldorf, North Rhine-Westphalia, Germany
    Recruiting
  • TU Chemnitz, Sports Medicine and Exercise Therapy
    Chemnitz, Saxony, Germany
    Recruiting
  • Institute for Applied Training Science (IAT) Leipzig
    Leipzig, Saxony, Germany
    Recruiting
Show 2 more locations
  • University of Limerick, Department of Physical Education and Sport Sciences (PESS)
    Limerick, Limerick, Ireland
    Recruiting
  • Universidad Politécnica de Madrid, Facultad de Ciencias de la Actividad Física y del Deporte (INEF)
    Madrid, Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.